Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA
| 68233JBH6 | 94.92 0.00 0.00% |
About 62% of ONCOR's investor base is looking to short. The analysis of the overall prospects from investing in ONCOR ELEC DELIVERY suggests that many traders are, at the present time, alarmed. The current market sentiment, together with ONCOR's historical and current headlines, can help investors time the market. In addition, many technical investors use ONCOR ELEC DELIVERY bond news signals to limit their universe of possible portfolio assets.
ONCOR |
To potentially include adolescents and antibody persistence up to two years Saint Herblain , November 26, 2024 Valneva SE , a specialty vaccine company, today announced that it has submitted a label extension application to the U.S. Food and Drug Administration to potentially extend the use of its chikungunya vaccine IXCHIQ, which is currently approved in adults, to adolescents aged 12 to 17 years. The application also includes adding the two-y
Read at finance.yahoo.com
 |
ONCOR Fundamental Analysis
We analyze ONCOR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ONCOR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ONCOR based on its fundamental data. In general, a quantitative approach, as applied to this corporate bond, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
ONCOR ELEC cannot be rated in Probability Of Bankruptcy category at this point.Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
ONCOR ELEC DELIVERY Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ONCOR bond to make a market-neutral strategy. Peer analysis of ONCOR could also be used in its relative valuation, which is a method of valuing ONCOR by comparing valuation metrics with similar companies.
Peers
ONCOR Related Equities
| BREA | Brera Holdings | 25.00 | ||||
| 00108WAF7 | 00108WAF7 | 8.10 | ||||
| PFE | Pfizer | 1.47 | ||||
| FTNT | Fortinet | 1.05 | ||||
| JXN-PA | Jackson Financial | 1.03 | ||||
| MET | MetLife | 0.02 | ||||
| CSCO | Cisco Systems | 0.13 | ||||
| JNJ | Johnson Johnson | 0.25 | ||||
| T | ATT | 0.47 | ||||
| 90331HPL1 | 90331HPL1 | 2.13 |
Other Information on Investing in ONCOR Bond
ONCOR financial ratios help investors to determine whether ONCOR Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ONCOR with respect to the benefits of owning ONCOR security.